BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Press Releases

  OS Therapies Announces FDA OST-HER2 Type D Meeting Elevated to Type B Pre-BLA Meeting

  March 9, 2026

   · 

  5 min read
• Press Releases

  Telo Genomics Closes Second and Final Tranche of Convertible Debentures Financing

  March 9, 2026

   · 

  5 min read
• Press Releases

  Theralase(R) Demonstrates That X-Ray-Activated Rutherrin(R) Is Significantly More Effective than Radiation Alone in the Destruction of Muscle Invasive Bladder Cancer

  March 9, 2026

   · 

  1 min read
• Press Releases

  Lyell Immunopharma Announces Closing of Additional $50 Million Tranche of Equity Private Placement and Appointment of Smital Shah as Chief Financial and Business Officer

  March 9, 2026

   · 

  6 min read
• Press Releases

  SpyGlass Pharma Announces Positive Topline 12-Month Phase 1/2 Trial Results for Its Innovative BIM-IOL System

  March 9, 2026

   · 

  7 min read
• Press Releases

  Keros Therapeutics Presents Additional Clinical Data from Its Rinvatercept Program at the 2026 MDA Clinical & Scientific Conference

  March 9, 2026

   · 

  6 min read
• Press Releases

  LB Pharmaceuticals Appoints R&D Biotech Executive Robert Lenz, M.D., Ph.D. to Board of Directors

  March 9, 2026

   · 

  4 min read
• Press Releases

  Route 92 Medical Enrolls First Patient in SUMMIT RISE Study

  March 9, 2026

   · 

  3 min read
• Press Releases

  Nasus Pharma to Present and Participate in the Upcoming Life Sciences Investor Forum

  March 9, 2026

   · 

  1 min read
• Press Releases

  Defence Therapeutics Announces Closing of Private Placement of Units for Gross Proceeds of $9,595,000

  March 9, 2026

   · 

  4 min read